Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 7, Pages 1800
Publisher
MDPI AG
Online
2020-07-06
DOI
10.3390/cancers12071800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Status of Programmed Death Ligand 1 (PD-L1) by immunohistochemistry and scoring algorithms
- (2020) Francesca Giunchi et al. CURRENT DRUG TARGETS
- A Machine-learning Approach for the Assessment of the Proliferative Compartment of Solid Tumors on Hematoxylin-Eosin-Stained Sections
- (2020) Francesco Martino et al. Cancers
- The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience
- (2019) Elena Vigliar et al. Biomed Research International
- Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
- (2019) Gabriele Campanella et al. NATURE MEDICINE
- “Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy
- (2019) Emina Torlakovic et al. MODERN PATHOLOGY
- Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
- (2019) Fabio Pagni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer
- (2019) Julien Mazieres et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non–Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs
- (2018) Enrico Munari et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer
- (2018) J Adam et al. ANNALS OF ONCOLOGY
- Predictive Performance of Four Programmed Cell Death Ligand 1 Assay Systems on Nivolumab Response in Previously Treated Patients with Non–Small Cell Lung Cancer
- (2018) Daichi Fujimoto et al. Journal of Thoracic Oncology
- PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
- (2018) Ming Sound Tsao et al. Journal of Thoracic Oncology
- Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer
- (2018) Shona Hendry et al. Journal of Thoracic Oncology
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Artificial intelligence-the third revolution in pathology
- (2018) Manuel Salto-Tellez et al. HISTOPATHOLOGY
- Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer
- (2017) Reinhard Büttner et al. JOURNAL OF CLINICAL ONCOLOGY
- Future-proofing pathology: the case for clinical adoption of digital pathology
- (2017) Bethany Jill Williams et al. JOURNAL OF CLINICAL PATHOLOGY
- Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors
- (2017) Antonio Marchetti et al. Journal of Thoracic Oncology
- PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
- (2017) Fred R. Hirsch et al. Journal of Thoracic Oncology
- PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
- (2017) Hyojin Kim et al. Oncotarget
- A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer
- (2017) David L. Rimm et al. JAMA Oncology
- Digital pathology in clinical use: where are we now and what is holding us back?
- (2016) Jon Griffin et al. HISTOPATHOLOGY
- PD-L1 Expression in Lung Cancer
- (2016) Hui Yu et al. Journal of Thoracic Oncology
- Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
- (2016) Andreas H Scheel et al. MODERN PATHOLOGY
- Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
- (2016) Joseph McLaughlin et al. JAMA Oncology
- Validating Whole Slide Imaging for Diagnostic Purposes in Pathology: Guideline from the College of American Pathologists Pathology and Laboratory Quality Center
- (2013) Liron Pantanowitz et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started